1. Home
  2. HHS vs FBRX Comparison

HHS vs FBRX Comparison

Compare HHS & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HHS
  • FBRX
  • Stock Information
  • Founded
  • HHS 1923
  • FBRX N/A
  • Country
  • HHS United States
  • FBRX United States
  • Employees
  • HHS N/A
  • FBRX N/A
  • Industry
  • HHS Advertising
  • FBRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HHS Consumer Discretionary
  • FBRX Health Care
  • Exchange
  • HHS Nasdaq
  • FBRX Nasdaq
  • Market Cap
  • HHS 37.0M
  • FBRX 35.3M
  • IPO Year
  • HHS N/A
  • FBRX N/A
  • Fundamental
  • Price
  • HHS $4.66
  • FBRX $7.34
  • Analyst Decision
  • HHS
  • FBRX Strong Buy
  • Analyst Count
  • HHS 0
  • FBRX 3
  • Target Price
  • HHS N/A
  • FBRX $80.50
  • AVG Volume (30 Days)
  • HHS 20.9K
  • FBRX 50.8K
  • Earning Date
  • HHS 05-08-2025
  • FBRX 05-12-2025
  • Dividend Yield
  • HHS N/A
  • FBRX N/A
  • EPS Growth
  • HHS N/A
  • FBRX N/A
  • EPS
  • HHS N/A
  • FBRX N/A
  • Revenue
  • HHS $185,242,000.00
  • FBRX N/A
  • Revenue This Year
  • HHS $6.54
  • FBRX N/A
  • Revenue Next Year
  • HHS N/A
  • FBRX N/A
  • P/E Ratio
  • HHS N/A
  • FBRX N/A
  • Revenue Growth
  • HHS N/A
  • FBRX N/A
  • 52 Week Low
  • HHS $4.27
  • FBRX $4.11
  • 52 Week High
  • HHS $8.87
  • FBRX $28.68
  • Technical
  • Relative Strength Index (RSI)
  • HHS 48.35
  • FBRX 52.55
  • Support Level
  • HHS $4.30
  • FBRX $5.25
  • Resistance Level
  • HHS $4.72
  • FBRX $6.43
  • Average True Range (ATR)
  • HHS 0.39
  • FBRX 0.82
  • MACD
  • HHS 0.02
  • FBRX 0.21
  • Stochastic Oscillator
  • HHS 47.56
  • FBRX 57.71

About HHS Harte-Hanks Inc.

Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).

Share on Social Networks: